Vent Creativity is transforming surgical planning with its AI-driven Minerva platform, offering faster, simpler, and more precise solutions.
Vent Creativity, an innovative leader in surgical planning software, is redefining the landscape of orthopedic surgery with its advanced, AI-driven tools. Six months after joining NVIDIA Inception, a program designed to support startups pushing technological boundaries, Vent Creativity continues to advance its mission to improve surgical outcomes through the application of generative AI and digital-twin technologies.
VENT products are currently for research use only and are not commercially available for clinical use in the USA
A Revolution in Surgical Planning
At the heart of Vent Creativity’s offerings is the Minerva platform, a cloud-based surgical planning solution that integrates advanced AI and machine learning to facilitate rapid, accurate surgical planning. Minerva allows medical device manufacturers and surgeons to review 3D models of patient anatomy and extract actionable insights from medical images. The platform’s efficiency is a game-changer: where traditional systems can take up to seven hours to generate surgical plans, Minerva completes the task in just 15 minutes. This significant reduction in processing time translates directly into cost savings for healthcare providers and enhanced care for patients.
The Minerva platform’s efficiency and precision are bolstered by Vent Creativity’s patented technology, which includes sophisticated density mapping capabilities. This feature is especially critical in orthopedic surgery, where understanding the distribution and characteristics of bone density can be the difference between successful and suboptimal outcomes. By providing detailed maps of bone density, Minerva enables surgeons to make more informed decisions about implant placement and bone preservation, ultimately improving the likelihood of successful surgeries.
Simplifying Complex Procedures
Vent Creativity’s platform goes beyond just speeding up the surgical planning process. It also simplifies it by reducing the dependency on expensive, complicated segmentation software. The traditional approach to surgical planning often involves intricate pre-planning procedures that require specialized software to segment medical images into usable data. Minerva’s point-cloud approach bypasses this complexity, allowing surgeons and medical device manufacturers to focus on what matters most: planning and executing surgeries with precision.
Complementing Minerva are other powerful tools in Vent Creativity’s portfolio. DICOMtoplan is an essential tool that allows users to upload DICOM files to the cloud for principal density analysis and automatic landmark generation. This tool is particularly useful for surgical planning, as it quickly identifies key anatomical landmarks and provides essential data for planning interventions.
inVENT, another innovative tool from Vent, is a web-based user interface that displays 3D bone density models and offers digital-twin surgical planning options. By simulating different surgical scenarios, inVENT helps surgeons visualize potential outcomes before ever making an incision, reducing the risks associated with complex procedures.
These tools, while currently only available for research purposes, have already made a significant impact on how surgical planning is approached in the orthopedic field. The rapid processing times, coupled with advanced data analysis and visualization capabilities, make Vent Creativity’s offerings indispensable for those involved in implant design and surgical research.
Expanding Capabilities with NVIDIA Inception
In January 2024, Vent Creativity announced its participation in NVIDIA Inception, a strategic move that has since propelled the company’s growth and development. NVIDIA Inception is known for nurturing startups that are revolutionizing industries through technological advancements, and Vent’s inclusion in the program has provided invaluable resources for the company.
Through NVIDIA Inception, Vent Creativity has gained access to advanced AI training, augmented reality capabilities, and exclusive technological insights. These resources have been instrumental in enhancing the Minerva platform, particularly in the areas of AI training and the integration of augmented reality features. Vent has also had the opportunity to collaborate with industry-leading experts and other AI-driven organizations, accelerating the development of its surgical planning tools and ensuring that they remain at the forefront of technological innovation.
“NVIDIA, with its world-renowned reputation in AI, has provided us with unique opportunities that are invaluable as we continue to push the boundaries of what’s possible in surgical planning,” according to Gilly Yildirim, CEO of Vent Creativity. “The support and expertise we’ve received through the Inception program have been crucial in helping us achieve our mission of improving healthcare for all.”
Looking Ahead: Clinical Applications on the Horizon
While Vent Creativity’s products are currently limited to research use, the company is making significant strides toward bringing its technologies into clinical settings. An FDA application is expected later this year, which, if successful, will open the door for Minerva and its associated tools to be used in clinical environments across some of the world’s leading orthopedic hospitals.
This potential expansion into clinical use marks a significant milestone for Vent Creativity. The ability to use these tools in a clinical setting could transform how surgeries are planned and executed, leading to better outcomes for patients and more efficient processes for healthcare providers.
In the meantime, Vent Creativity continues to support implant manufacturers with tools and services designed to verify and validate implant designs. The company’s offerings include digital twin simulations for density and stress-based modeling, as well as segmentation, landmarking, and surgical planning services directly from DICOM files. These tools are critical for informing implant design teams and ensuring that new products are both safe and effective before they reach the market.
As Vent Creativity looks to the future, its commitment to innovation and improving healthcare remains steadfast. The company’s AI-powered surgical planning tools are not only speeding up the planning process but are also making it more accurate and accessible. With the potential for clinical use on the horizon, Vent Creativity is poised to become a key player in the field of orthopedic surgery, offering solutions that could revolutionize patient care worldwide.
